In the context of cancer, TIM-3 expression has been found to be a marker of CD8 tumor-infiltrating T lymphocytes (TILs) dysfunctionality and Treg expansion, and correlates with tumor progression [139]. This evidence concerns the gene HAVCR2 and neoplasm.